ACMG Studies Provide Lessons in Genetic Test Ordering Management
As use of clinical molecular testing skyrockets, many believe a closer examination of ordering patterns is warranted. Molecular tests have the potential to offer key diagnostic information. However, if not properly ordered these tests can be expensive and still not provide the needed answers to key clinical questions. A few early studies have shown that misorders are common and can result from clerical errors, misunderstanding of genetics, or inappropriate testing sequences. These misorders can both be costly to the health care system and delay appropriate diagnosis and treatment. As a result of increasing health care costs associated with molecular testing, many institutions are undertaking a review of test orders in formal genetic test utilization management (GTUM) programs. Three studies presented recently at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting (Tampa, Florida; March 8-12) demonstrate the savings associated with improving molecular test ordering practices. The early results of existing GTUM programs can provide guidance to laboratories and medical systems on the benefits of reviewing genetic test orders. Substantial Savings Realized Through Test Review GTUM led to improved financial management of the testing process, including limiting of patient financial liability and increasing institutional reimbursement, according to […]
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article